Dr. Yuxun Wang


Dr. Yuxun Wang is currently the Chief Scientific Officer at Pharscin Pharmaceutical Co Ltd. From 2015 to 2020, he served as Vice President of Biology and then Vice President of Biology and Translational Medicine at Denovo Pharmatech Co Ltd. where he envisioned and built innovative drug discovery platforms and teams.
He initiated eight new projects and developed the company’s R&D strategy and pipeline focusing on cancer and immuno-oncology. During his tenure at Denovo Pharmatech, three programs entered clinical trials including the company’s first clinical trials in the US. From 2012 to 2015, he served in leadership positions responsible for cancer drug discovery services and management at top CRO companies.
Dr. Wang has more than 20 years of cancer research experience from both academia and industry. Previously, he served as a senior research biologist at Merck & Co., Inc. and associate director at Metamark Genetics Inc. in the US.